LeanLife Health Inc.
LNLHF · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.23 | 0.06 | 0.04 | -0.02 |
| FCF Yield | -10.73% | -5.23% | -38.21% | -40.04% |
| EV / EBITDA | -3.71 | -1.80 | -1.48 | -2.43 |
| Quality | ||||
| ROIC | -712.88% | 200.16% | -913.32% | -645.08% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.42 | 0.14 | 0.74 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -501.14% | 85.30% | 33.25% | -164.67% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.14 | 0.01 | 0.02 |
| Interest Coverage | -535.66 | -5,449.77 | -1,853.86 | -2,050.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | -0.10 | 0.00 | 0.00 |
| Cash Conversion Cycle | 5,053.00 | -73,702.87 | -11,638.28 | -15,185.58 |